1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane has been researched along with sr 95531 in 1 studies
Studies (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Trials (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Recent Studies (post-2010) (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) |
---|---|---|---|---|---|
40 | 0 | 5 | 610 | 0 | 209 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kakemoto, E; Nagata, K; Okuyama, E; Ozoe, Y | 1 |
1 other study(ies) available for 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and sr 95531
Article | Year |
---|---|
Interaction of anisatin with rat brain gamma-aminobutyric acidA receptors: allosteric modulation by competitive antagonists.
Topics: Affinity Labels; Allosteric Regulation; Androstanes; Animals; Azasteroids; Binding Sites; Binding, Competitive; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; GABA Antagonists; In Vitro Techniques; Lactones; Pyridazines; Rats; Receptors, GABA-A; Sesquiterpenes; Spiro Compounds; Tritium | 1999 |